Toxoplasma gondii Type I TR and ROP16 Synergistically Downregulate IL-12 to Inhibit Host Reactive Oxygen Species Production
Open Access
Abstract
Toxoplasma gondii is an obligate intracellular opportunistic protozoan parasite. T. gondii invasion disturbs the balance between reactive oxygen species (ROS) production and antioxidant capacity in the host, triggering the oxidative stress response. Thioredoxin reductase (TR) of T. gondii helps to escape ROS-induced damage in the host, whereas T. gondii rhoptry protein 16 (ROP16) downregulates host innate immunity to suppress excessive inflammation and inhibit ROS production. However, whether TR and ROP16 synergistically promote resistance to ROS-induced damage remains unclear. Here, we used the CRISPR/Cas9 technology to successfully obtain a double TR and ROP16 gene knockout T. gondii strain. The double deletion of TR and ROP16 in T. gondii weakened its growth ability in vitro and decreased its virulence in vivo. Moreover, the double deletion of TR and ROP16 resulted in a lower antioxidant capacity, higher degree of lipid oxidation, and elevated ROS levels in the parasite and host cells. Interestingly, the deletion of the TR and ROP16 genes in T. gondii synergistically increased IL-12 levels, which triggered host cells to produce more ROS to resist T. gondii infection. These results show that TR and ROP16 in T. gondii play a synergistic role, facilitating resistance to ROS damage incurred by host immune cells through different pathways.Keywords
Funding Information
- Natural Science Foundation of Shanghai (22ZR1476000, 2022-02-08-00-12-F01085)
- Shanghai Science and Technology Promotion Agriculture Innovation Program (22ZR1476000, 2022-02-08-00-12-F01085)
This publication has 46 references indexed in Scilit:
- Changes in energy reserves and responses of some biomarkers in freshwater mussels exposed to metal-oxide nanoparticlesEnvironmental Toxicology and Pharmacology, 2023
- A serological survey of Toxoplasma gondii infection in sheep and goat from Benin, West-AfricaJournal of Parasitic Diseases, 2019
- Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeuticFree Radical Biology and Medicine, 2018
- Virulence factors of Toxoplasma gondiiMicrobes and Infection, 2012
- Transactivation of gene expression by NF-κB is dependent on thioredoxin reductase activityFree Radical Biology and Medicine, 2011
- Toxoplasma gondii: epidemiology, feline clinical aspects, and preventionTrends in Parasitology, 2010
- The Relationship of the Redox Potentials of Thioredoxin and Thioredoxin Reductase fromDrosophila melanogasterto the Enzymatic Mechanism: Reduced Thioredoxin Is the Reductant of Glutathione inDrosophilaBiochemistry, 2007
- Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologueNature, 2006
- Subversion of innate and adaptive immune responses by Toxoplasma GondiiParasitology Research, 2006
- ToxoplasmosisThe Lancet, 2004